Table 1 Individual demographic and preswitch data for 11 patients with Fabry disease who switched from agalsidase beta to agalsidase alfa

From: Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal)